Enzymatica AB (ENZY)
Market Closed
10 Aug, 15:25
XSTO XSTO Primary 
XSTU kr
1. 91
+0.03
+1.6%
kr
604.41M Market Cap
- P/E Ratio
- Div Yield
18,676 Volume
-0.2 Eps
kr 1.88
Previous Close Want to track ENZY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
ENZY closed today higher at kr1.91, an increase of 1.6% from yesterday's close, completing a monthly decrease of -24.7036% or -kr0.62. Over the past 12 months, ENZY stock lost -0.2618%.
ENZY is not paying dividends to its shareholders.
The last earnings report, released on Apr 23, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0267%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XSTO (SEK).
Enzymatica AB (ENZY) FAQ
What is the stock price today?
The current price is kr1.91.
On which exchange is it traded?
Enzymatica AB is listed on XSTO.
What is its stock symbol?
The ticker symbol is ENZY.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 604.41M.
Has Enzymatica AB ever had a stock split?
No, there has never been a stock split.
Enzymatica AB Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Sana Alajmovic CEO | XSTO Exchange | SE0003943620 ISIN |
| SE Country | 20 Employees | - Last Dividend | 23 Aug 2024 Last Split | - IPO Date |
Overview
Enzymatica AB (publ) is a life science company established in 2007, with its headquarters located in Lund, Sweden. The company specializes in developing and marketing products designed to treat and alleviate infections and symptoms in the upper respiratory tract. Enzymatica's business model involves collaborating with contract organizations and engaging in partner agreements with distributors for the sale of its products. These products are sold under various brand names, including ViruProtect, STADAProtect, and Bisolviral, depending on the geographical location and distribution agreement.
Products and Services
- ColdZyme: This is Enzymatica's flagship product, a mouth spray aimed at treating and alleviating symptoms of cold and flu. ColdZyme is designed to create a protective barrier in the throat against common cold viruses, thereby offering relief from symptoms and possibly shortening the duration of a cold.
- Enzyme Formulations for Skin Care: In addition to its respiratory products, Enzymatica AB develops enzyme-based formulations for skin care. These products leverage the natural properties of enzymes to promote healthy skin, offering a unique approach to skincare that complements traditional methods.
Contact Information
Address: Ideon Science Park, Lund, Sweden, 223 70
Phone: 46 4 62 86 31 00
Website: https://www.enzymatica.com
